Copyright
©The Author(s) 2015.
World J Gastroenterol. Nov 21, 2015; 21(43): 12421-12429
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12421
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12421
Figure 1 Flow chart illustrating patient selection and categorization based on EASL.
CHB: Chronic hepatitis B; ETV: Entecavir; CVR: Complete virological response; EASL-baseline critical: HBV DNA levels at week 48 in patients treated by entecavir.
- Citation: Li N, Xu JH, Yu M, Wang S, Si CW, Yu YY. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy. World J Gastroenterol 2015; 21(43): 12421-12429
- URL: https://www.wjgnet.com/1007-9327/full/v21/i43/12421.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i43.12421